IPRATROPIUM for Psoriasis: Side Effects & Safety Data
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
There are 6 adverse event reports in the FDA FAERS database where IPRATROPIUM was used for Psoriasis.
Most Reported Side Effects for IPRATROPIUM
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Asthma | 2,596 | 34.4% | 62 | 1,780 |
| Dyspnoea | 2,450 | 32.5% | 161 | 1,528 |
| Wheezing | 1,910 | 25.3% | 20 | 1,270 |
| Cough | 1,315 | 17.4% | 36 | 783 |
| Therapeutic product effect incomplete | 1,229 | 16.3% | 3 | 729 |
| Obstructive airways disorder | 1,171 | 15.5% | 22 | 819 |
| Drug ineffective | 1,057 | 14.0% | 133 | 686 |
| Pneumonia | 931 | 12.4% | 115 | 658 |
| Loss of personal independence in daily activities | 861 | 11.4% | 0 | 520 |
| Chest discomfort | 785 | 10.4% | 35 | 434 |
| Sleep disorder due to a general medical condition | 743 | 9.9% | 0 | 395 |
| Off label use | 651 | 8.6% | 242 | 323 |
| Chronic obstructive pulmonary disease | 629 | 8.3% | 142 | 508 |
| Condition aggravated | 595 | 7.9% | 238 | 377 |
| Vomiting | 580 | 7.7% | 237 | 316 |
Other Indications for IPRATROPIUM
Product used for unknown indication (4,041)
Asthma (794)
Chronic obstructive pulmonary disease (598)
Dyspnoea (538)
Sleep disorder therapy (235)
Cough (166)
Rhinorrhoea (132)
Nasopharyngitis (108)
Secretion discharge (105)
Pneumothorax (97)
Other Drugs Used for Psoriasis
APREMILAST (76,127)
SECUKINUMAB (58,471)
ADALIMUMAB (56,634)
RISANKIZUMAB-RZAA (40,890)
ETANERCEPT (30,483)
USTEKINUMAB (21,763)
IXEKIZUMAB (16,569)
GUSELKUMAB (11,736)
CERTOLIZUMAB PEGOL (8,179)
METHOTREXATE (6,628)